These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3127910)

  • 21. Evaluation of aflatoxin B1 embryotoxicity using the frog embryo teratogenesis assay-Xenopus and bio-activation with microsome activation systems.
    Vismara C; Caloni F
    Birth Defects Res B Dev Reprod Toxicol; 2007 Jun; 80(3):183-7. PubMed ID: 17443695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P-450 system of rat liver.
    Yoshizawa H; Uchimaru R; Kamataki T; Kato R; Ueno Y
    Cancer Res; 1982 Mar; 42(3):1120-4. PubMed ID: 6800645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of DNA single-strand breaks and DNA synthesis inhibition by patulin, ochratoxin A, citrinin, and aflatoxin B1 in cell lines CHO and AWRF.
    Stĕtina R; Votava M
    Folia Biol (Praha); 1986; 32(2):128-44. PubMed ID: 3087796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grapefruit juice intake does not enhance but rather protects against aflatoxin B1-induced liver DNA damage through a reduction in hepatic CYP3A activity.
    Miyata M; Takano H; Guo LQ; Nagata K; Yamazoe Y
    Carcinogenesis; 2004 Feb; 25(2):203-9. PubMed ID: 14578159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro embryotoxicity of 5-fluorouracil in rat embryos.
    Grafton TF; Bazare JJ; Hansen DK; Sheehan DM
    Teratology; 1987 Dec; 36(3):371-7. PubMed ID: 3424225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.
    Leadon SA; Tyrrell RM; Cerutti PA
    Cancer Res; 1981 Dec; 41(12 Pt 1):5125-9. PubMed ID: 6796265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
    Hayes JD; Judah DJ; Neal GE
    Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative kinetic studies on aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation with rat and hamster livers in vitro.
    Raj HG; Clearfield MS; Lotlikar PD
    Carcinogenesis; 1984 Jul; 5(7):879-84. PubMed ID: 6428765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of aflatoxin B1 on monooxygenase activity in liver microsomes exposed to cytochrome P-450].
    Astashkin EI; Prikhodko AZ
    Vopr Pitan; 1994; (6):6-8. PubMed ID: 7732678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of S9 mix and hepatocytes as external metabolizing systems in mammalian cell cultures: cytogenetic effects of 7,12-dimethylbenzanthracene and aflatoxin B1.
    Madle E; Tiedemann G; Madle S; Ott A; Kaufmann G
    Environ Mutagen; 1986; 8(3):423-37. PubMed ID: 3086074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man?
    Plummer S; Boobis AR; Davies DS
    Arch Toxicol; 1986 Feb; 58(3):165-70. PubMed ID: 3083802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic activation and bacterial mutagenicity of aflatoxin B1 in two different test systems.
    Lowery C; Orton TC; Garner RC
    Toxicology; 1983 Dec; 29(1-2):131-41. PubMed ID: 6419391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational specificity of aflatoxin B1. Comparison of in vivo host-mediated assay with in vitro S9 metabolic activation.
    Prieto-Alamo MJ; Jurado J; Abril N; Díaz-Pohl C; Bolcsfoldi G; Pueyo C
    Carcinogenesis; 1996 Sep; 17(9):1997-2002. PubMed ID: 8824526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryotoxicity assay of aflatoxin produced by Aspergillus parasiticus NRRL 2999.
    Celik I; Oğuz H; Demet O; Boydak M; Dönmez HH; Sur E; Nizamlioğlu F
    Br Poult Sci; 2000 Sep; 41(4):401-9. PubMed ID: 11128380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex dependence of the metabolic activation in vitro of the mycohepatocarcinogen aflatoxin B1.
    Gurtoo HL; Motycka LE; Parker NB
    J Med; 1976; 7(1):1-12. PubMed ID: 1064676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic lipid peroxidation and intracellular calcium accumulation in ethanol potentiated aflatoxin B1 toxicity.
    Toskulkao C; Glinsukon T
    J Pharmacobiodyn; 1988 Mar; 11(3):191-7. PubMed ID: 3137321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation by some natural carotenoids of DNA adduct formation by aflatoxin B1 in vitro.
    Goswami UC; Saloi TN; Firozi PF; Bhattacharya RK
    Cancer Lett; 1989 Sep; 47(1-2):127-32. PubMed ID: 2517591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.